Mimesis Law
16 August 2018

IP Flow

Yeah!

Cutting edge analysis and commentary at the intersection of Intellectual Property Law and Investing.

  • The Markman Note: Activists at Qualcomm’s Gate

    by - Apr 21, 2015
    (Comments: 2)
    Apr. 21, 2015 (Mimesis Law) — It was another busy week at the intersection of investing and intellectual property, with continued patent litigation activity of interest to investors — across a number of industry sectors. Welcome...
  • Markman Minute: Takeaways From Marvell Oral Arguments

    by - Apr 16, 2015
    (Comments: 1)
    Apr. 16, 2015 (Mimesis Law) — Oral arguments were recently heard at the US Court of Appeals in Washington DC in the appeal of a massive $1.5 billion patent infringement verdict against Marvell Semiconductor in the...
  • Markman Minute: Rovi Takes On Netflix

    by - Apr 11, 2015
    (Comments: 2)
    Apr. 11, 2015 (Mimesis Law) — Gaston breaks down what’s at stake for companies and shareholders in the latest stage of Rovi’s patent infringement fight against Netflix....Read More
  • The Markman Note: Rovi on the Ropes?

    by - Apr 2, 2015
    (Comments: 0)
    Apr. 2, 2015 (Mimesis Law) — It was a wild week at the intersection of investing and intellectual property, with four big litigation-induced moves in some names that we have been monitoring for a while. Welcome...
  • Markman Minute: Marvell’s Billion Dollar Fight

    by - Mar 31, 2015
    (Comments: 3)
    Mar. 31, 2015 (Mimesis Law) — After losing the largest patent verdict to date, Marvell Technology Group looks to oral arguments in the appeal the over $1.5 billion decision favoring Carnegie Mellon. Gaston breaks down what...
  • The Markman Note: Marvell, Enzo Biochem, Spherix

    by - Mar 23, 2015
    (Comments: 1)
    Mar. 24, 2015 (Mimesis Law) — Welcome to the first issue of the Markman Note, a special section on Mimesis Law focusing on the intersection of investing and intellectual property. ¬†For the most part we’ll be...

IP Flow Mailing List

Subscribe to our mailing list

* indicates required

Cy-Pher Mailing List

Subscribe to our mailing list

* indicates required